Skip to content

Six- and nine-month courses of TB treatment equivalent in Indian HIV-positive patients

Highly sensitive method uncovers high levels of resistance in mothers given single-dose nevirapine

Addition of capravirine to a three-drug regimen not beneficial in patients with NNRTI resistance

Single-dose nevirapine reduces HIV transmission in second delivery

Long-term CD4 increase on HAART averages 250-350 cells, plateaus after 3-4 years

The ‘New York case’: details revealed at Boston conference

Pregnancy doubles the risk of HIV infection

Switch to tenofovir better than change to abacavir?

NNRTI-based HAART effective in Thai children